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Introduction
Antimicrobial peptides ( AMPs ) are small, positively
charged, amphipathic structures possessing both hydrophobic
and hydrophilic regions of variable amino acid composition
(length < 100 amino acids) (Brogden, 2005). They are also
known as host defense peptides because of their essential
role in the innate immunity system. AMPs exhibit broad−
spectrum antimicrobial activities against various microorgan-
isms, including Gram−positive and Gram−negative bacteria,
fungi and viruses (Hancock & Diamond, 2000 ) . Several
AMPs are known to be effective against multi−drug resistant
bacteria, and possesses a low propensity for resistance devel-
opment (van t Hof W et al., 2001). Among the 112 host de-
fense peptides identified in humans, the cathelicidins, de-
fensins and ribonuclease families are the most prominent
(Wang et al., 2009). RNase A superfamily is one of the best
− characterized ribonucleases and consists of 13 subtypes
(Becknell et al. , 2015). Among them, RNase 7 is most
abundantly found in the skin and expressed in various epi-
thelial tissues such as the genitourinary, respiratory, and gas-
trointestinal tissues (Amatngalim et al., 2015 ; Eberhard J et
al., 2008 ; Harder & Schroder, 2002 ; Spencer et al., 2011).
RNase 7 expression has been reported in the oral epithelium,
and it is suggested to be involved in host defense in the oral
cavity (Eberhard et al., 2008). Although certain types of host
defense peptides including cathelicidins, defensins and ribo-
nucleases may contribute to causing several diseases, there is
little information about the involvement of RNase 7 in oral
epithelial diseases. Therefore, this mini−review mainly fo-
cuses on the roles of RNase 7 in epithelial health and dis-
ease with emphasis on its involvement in oral epithelial dis-
eases.
Overview of RNase 7
All 13 RNase subtypes are encoded in a single gene clus-
ter in chromosome 14. RNases 1–8 are called as canonical
RNases (true RNases), while the remaining five (RNase 9–
13) are known as non−canonical RNases (Boix & Nogues,
2007 ; Cho et al., 2005 ; Sorrentino, 2010), which lack the
catalytic triad and may therefore be incapable of catalyzing
RNA degradation. Besides their ribonucleolytic activity, ca-
nonical RNases have been shown to play roles in angiogene-
sis, neurotoxicity, immunomodulation, and host defense
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Abstract
The oral epithelium is normally protected from vari-
ous stimuli within the diverse environment of the oral
cavity. This review focuses on RNase 7, a potent epi-
thelium−derived antimicrobial peptide, and discusses its
importance in oral health and disease. RNase 7 exhibits
high antimicrobial activity against a broad spectrum of
microorganisms. The expression of RNase 7 in the oral
epithelium is induced by stimulation with oral bacterial
biofilms and several cytokines. Studies have identified
numerous beneficial effects of this peptide, such as the
prevention of bacterial infections and its use as a poten-
tial therapeutic agent. However, there is little informa-
tion on the alterative expression and roles of RNase 7
in oral inflammatory disease and cancer, which merits
further investigations.
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(Boix & Nogues, 2007 ; Goo & Cho, 2013 ; Simanski et al.,
2012 ; Rosenberg, 2008). RNase 7 is a canonical RNases
found most abundantly in the skin (Harder & Schroder,
2002 ) , where the keratinocytes are the major source of
RNase 7 and the RNase inhibitor (RI). Structurally, RNase 7
is composed of three α−helices and two triple−stranded anti-
parallel β−sheets (Harder & Schroder, 2002 ; Huang et al.,
2007). The lysine residue from flexible N and C terminal
cationic cluster has a key role in antimicrobial activities ;
RNase 7 has the special capacity to permeate and disrupt the
bacterial membrane independent of its RNase activity, thus
differentiating it from the other RNases (Huang et al., 2007).
Instead of interacting with internal microbial targets, RNase
7 forms a complex with the surface proteins on some bacte-
ria (Torrent et al., 2010).
Role of RNase 7 in host defense of oral cavity
The oral epithelium is constantly exposed to various mi-
croorganisms, including commensals and pathogens present
in the diverse environment of the oral cavity (Presland &
Dale, 2000). A healthy oral status is maintained by the in-
nate immune system, which augments physical and chemical
barriers in the oral epithelium (Dale, 2002 ; Ganz, 2004 ;
Eberhard et al., 2008 ; Rakoff−Nahoum et al., 2004). The
rigid intercellular connections between the epithelial cells act
as a physical barrier, while AMPs produced by the epithelial
cells function as a chemical barrier against pathogenic or-
ganisms (Abiko Y et al., 2007 ; Chung et al., 2007). AMPs
often play a significant role in adaptive immunity by recruit-
ing adaptive immune cells (Abiko Y et al., 2007). As shown
in Figure 1, the RNase 7 peptide is mainly localized in the
keratinized layers of normal skin and oral epithelium (Scola
et al., 2012 ; Rademacher et al., 2016). The expression of
RNase 7 is inhibited when it forms a complex with RI in the
basal and lower spinous layers. Furthermore, RNase 7 activ-
ity is unveiled following the degradation of RI by serine
proteases in the stratum corneum, thereby exerting its antim-
icrobial effects during the process of keratinocyte differentia-
tion (Fig.2) (Abtin et al., 2009). The expression of RNase 7
can be further enhanced by incubation with TNFα, IL−1β or
interferon γ (IFNγ), or by subjection to microbial challenge
with Pseudomonas aeruginosa , Escherichia coli , Staphylo-
coccus aureus , Staphylococcus epidermidis , Streptococcus
pyogenes, and Trichophyton rubrum (Harder & Schroder,
2002). RNase 7 expression has also been induced by bacte-
rial biofilms and protozoa in gingival and corneal epithelial
cells, respectively (Eberhard et al., 2008 ; Otri et al., 2010).
RNase 7 activity is more pronounced in early formed
biofilms than in matured biofilm (Eberhard et al., 2008), and
the induction of this peptide depends on the types of bacte-
rial species present in the biofilm (Eberhard et al., 2009).
RNase 7 in oral inflammatory diseases
There is very little information about the involvement of
RNase 7 in oral inflammatory diseases, thus far. Several
types of microbes are known to induce the expression of this
peptide ( Harder & Schroder, 2002 ; Rademacher et al. ,
2016) ; alternatively, upregulated RNase 7 expression has
been observed in other inflammatory diseases without micro-
bial infection. In psoriasis (chronic inflammatory skin dis-
ease), RNase 7 was found to be expressed in the psoriatic
scales, thus contributing to the low rates of infection.
(Harder & Schroder, 2005 ; Rademacher et al., 2016). The
increased expression of RNase 7 is induced by its immu-
neregulatory effects on activated T cells and on cytokines
such as TNF−α, and IFN−γ (Kopfnagel et al., 2017). Atopic
dermatitis also presented with increased levels of RNase 7
expression, which may have been induced by the disturbed
skin barrier (Harder et al., 2010).
Expression of T cell cytokines including TNF−α and IFN
−γ plays a role in the pathogenesis of oral lichen planus ;
Figure 1. Normal oral epithelium
Immunohistochemical staining showing positive staining of
RNase 7 in the keratinized layers of the normal oral epithelium.
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moreover, disturbed skin barriers due to T cell infiltration
are often observed in this condition (Nogueira et al., 2015).
Further studies investigating the significance of increased
RNase 7 expression levels in the pathogenesis of oral lichen
planus are warranted.
Role of RNase 7 in tumors
Certain types of AMPs demonstrate anticancer activities,
whereas others may exhibit oncogenic activities (Mader &
Hoskin, 2006 ; Gasper et al., 2013) such as the disruption of
the cell membrane. The cancer cell membrane typically car-
ries a net negative charge, which has an affinity towards cat-
ionic AMP (Cruciani et al., 1991). AMPs kill cancer cells
due to differences in cell membrane composition, cell sur-
face area, and fluidity when compared with the normal cells
( Leuschner & Hansel, 2004 ; Hoskin & Ramamoorthy,
2008). Thus, they may be clinically applied as potent anti-
cancer agents that kill the cancer cells and prevent metasta-
sis without causing damage to normal cells and tissues
(Papo & Shai, 2005). The expression level of RNase 7 in
cutaneous squamous cell carcinoma (SCC) has been found
to decrease with the malignant transformation indicating its
role as a tumor suppressor gene (Scola et al., 2012). On the
other hand, some AMPs have been found in progressing tu-
mors, and may be suitable for use as a tumor marker. In
head and neck cancer, the gene expression level of RNase 7
was higher in SCC than in normal tissues (Muehleisen et al.,
2012) . Furthermore, the expression level of peptide was
higher in SCC than in basal cell carcinoma, which presented
with lower malignant potential in the skin (Muehleisen et
al., 2012). These reports imply that RNase 7 may function
as an oncogene. The phenotype of the tumor cells varies
among the different types and sites of tumors. The expres-
sion levels and functions of RNase 7 may depend on the lo-
cation and types of the tumor. Therefore, further studies are
needed to better understand the mechanisms underlying the
variations in RNase 7 expression in different types of carci-
noma. Studies in the oral cavity, which is largely polluted
by several microbes, can provide more about inflammatory
diseases and their association with carcinoma. Knowledge
Figure 2. Healthy oral epithelium
RNase 7 is constitutively expressed in the keratinized layer but inhibited by the horseshoe
−shaped RNase inhibitor (RI) in other keratinocytes in healthy oral epithelium. RNase 7
is released after degradation of the RNase inhibitor (RI). RI is degraded by protease and
by the oxidation of its sulfhydryl groups, thus enabling RNase 7 activity.
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about the details of the expression patterns and functions of
RNase 7 in oral carcinoma may prove useful for the devel-
opment of cancer−targeted immune therapy.
Future aspects of RNase 7
RNase 7 is produced by the oral epithelium, and is known
to possess broad−spectrum antimicrobial activities against
oral pathogenic microbes. Studies undertaken in the area of
oral health have identified numerous beneficial effects of
this peptide, such as prevention of bacterial infections and
development of potential therapeutic agents ; however, there
is not enough evidence about its effect in oral diseases in-
cluding inflammatory diseases and tumors. Other types of
epithelial antimicrobial peptides such as beta−defensins are
directly involved in cancer prevention and in causing allergy
as well as autoimmune diseases (Prado−Montes de Oca E,
2010). Nevertheless, owing to limited information regarding
the involvement of RNase 7 in oral diseases, further investi-
gations clarifying its role are needed (Fig 3).
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